CXCL12, CXCR4 and CXCR7 Expression in brain metastases

Cancer Biology and Therapy

Volumn 8, Issue 17, 2009, Pages 1608-1614

  Salmaggi, Andrea ^a   Maderna, Emanuela ^a   Calatozzolo, Chiara ^a   Gaviani, Paola ^a   Canazza, Alessandra ^a   Milanesi, Ida ^a   Antonio, Silvani ^a   DiMeco, Francesco ^a   Carbone, Antonino ^b   Pollo, Bianca ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Brain metastasis; Chemokine; Clinical correlation; CXCL12; CXCR4; CXCR7; Immunohistochemistry

Indexed keywords

CHEMOKINE RECEPTOR CXCR; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN TISSUE; BREAST CARCINOMA; CELL NUCLEUS; CENTRAL NERVOUS SYSTEM TUMOR; CLEAR CELL CARCINOMA; CLINICAL EVALUATION; COLON CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVARY CARCINOMA; PROGNOSIS; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURVIVAL TIME; THYROID CARCINOMA; TUMOR CELL; TUMOR VASCULARIZATION;

ADULT; AGED; BRAIN NEOPLASMS; CHEMOKINE CXCL12; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, CXCR4; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 70350317612     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.17.9202     Document Type: Article

References (38)

1. Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol 2005; 75:5-14.
2. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37:745-751 (Pubitemid 27181303)
3. Bindal AK, Bindal RK, Hess KR, Shiu A, Hassenbusch SJ, Shi WM, et al. Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg 1996; 84:748-754 (Pubitemid 26120088)
4. Ewend MG, Elbabaa S, Carey LA. Current treatment paradigms for the management of patients with brain metastases. Neurosurgery 2005; 57:66-77. (Pubitemid 41579695)
5. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410:50-56 (Pubitemid 32225831)
6. Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenv. Blood 2006; 107:1761-1767
7. Liang Z, Wu T, Lou H, Yu X, Taichman RS, Lau SK, et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 2004; 64:4302-4308 (Pubitemid 38802437)
8. Andre F, Cabioglu N, Assi H, Sabourin JC, Delaloge S, Sahin A, et al. Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer. Ann Oncol 2006; 7:945-951 (Pubitemid 43778984)
9. Scala S, Ottaiano A, Ascierto PA, Cavalli M, Simeone E, Giuliano P, et al. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res 2005; 11:1835-1841 (Pubitemid 40471847)
10. Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, et al. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Clin Cancer Res 2006; 12:2795-2803 (Pubitemid 43752119)
11. Pan J, Mestas J, Burdick MD, Phillips RJ, Thomas GV, Reckamp K, et al. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol Cancer 2006; 5:56. (Pubitemid 44803715)
12. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, Strieter RM. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 2003; 167:1676-1686 (Pubitemid 36760683)
13. Lee BC, Lee TH, Avraham S, Avraham HK. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res 2004; 2:327-338 (Pubitemid 39025295)
14. Bian XW, Yang SX, Chen JH, Ping YF, Zhou XD, Wang QL, et al. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival. Neurosurgery 2007; 61:570-578 (Pubitemid 47442647)
15. Hinton CV, Avraham S, Avraham HK. Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain. Clin Exp Metastasis 2008; [Epub ahead of print].
16. Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 2005; 280:35760-35766 (Pubitemid 41532769)
17. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion and tumor development. J Exp Med 2006; 203:2201-2213 (Pubitemid 44352240)
18. Thelen M, Thelen S. CXCR7, CXCR4 and CXCL12: an eccentric trio? J Neuroimmunol 2008; 198:9-13.
19. Sierro F, Biben C, Martínez-Muñoz L, Mellado M, Ransohoff RM, Li M, et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci USA 2007; 104:14759-14764 (Pubitemid 350003216)
20. Miao Z, Luker KE, Summers BC, Berahovich R, Bhojani MS, Rehemtulla A, et al. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 2007; 104:15735-15740 (Pubitemid 350035369)
21. Wang J, Shiozawa Y, Wang J, Wang Y, Jung Y, Pienta KJ, et al. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem 2008; 283:4283-4294
22. Lazarini F, Tham TN, Casanova P, Arenzana-Seisdedos F, Dubois-Dalcq M. Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia 2003; 42:139-148 (Pubitemid 36565118)
23. Kang H, Watkins G, Douglas-Jones A, Mansel RE, Jiang WG. The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer. The Breast 2005; 14:360-367 (Pubitemid 41510192)
24. Salvucci O, Bouchard A, Baccarelli A, Deschênes J, Sauter G, Simon R, et al. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res Treat 2006; 97:275-283 (Pubitemid 43945757)
25. Wang N, Wu QL, Fang Y, Mai HQ, Zeng MS, Shen GP, et al. Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome. J Transl Med 2005; 3:26. (Pubitemid 41522081)
26. Spano JP, Andre F, Morat L, Sabatier L, Besse B, Combadiere C, et al. Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol 2004; 15:613-617 (Pubitemid 38559598)
27. Na IK, Scheibenbogen C, Adam C, Stroux A, Ghadjar P, Thiel E, et al. Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis. Hum Pathol 2008; 39:1751-1755
28. Shibuta K, Mori M, Shimoda K, Inoue H, Mitra P, Barnard GF. Regional expression of CXCL12/CXCR4 in liver and hepatocellular carcinoma and cell cycle variation during in vitro differentiation. Jpn J Cancer Res 2002; 93:789-797 (Pubitemid 34893475)
29. Tarasova NI, Stauber RH, Michejda CJ. Spontaneous and ligand-induced trafficking of CXC-Chemokine Receptor 4. J Biol Chem 1998; 273:15883-15886
30. Gortz A, Nibbs RJ, McLean P, Jarmin D, Lambie W, Baird JW, et al. The chemokine ESkine/CCL27 displays novel modes of intracrine and paracrine function. J Immunol 2002; 169:1387-1394 (Pubitemid 34809183)
31. Fischer T, Nagel F, Jacobs S, Stumm R, Schulz S. Reassessment of CXCR4 chemokine receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-2. PLoS ONE 2008; 3:4069.
32. Rempel SA, Dudas S, Ge S, Gutierrez JA. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 2000; 6:102-111 (Pubitemid 30064982)
33. Salmaggi A, Gelati M, Pollo B, Frigerio S, Eoli M, Silvani A, et al. CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells. J Neurooncol 2004; 67:305-317 (Pubitemid 39137361)
34. Liu YL, Yu JM, Song XR, Wang XW, Xing LG, Gao BB. Regulation of the Chemokine Receptor CXCR4 and Metastasis by Hypoxia-inducible Factor in Non Small Cell Lung Cancer Cell Lines. Cancer Biol Ther 2006; 5:1320-1326
35. Salvucci O, Yao L, Villalba S, Sajewicz A, Pittaluga S, Tosato G. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 2002; 99:2703-2711 (Pubitemid 34525355)
36. Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 2007; 28:299-307. (Pubitemid 46963141)
37. Kopp HG, Ramos CA, Rafii S. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr Opin Hematol 2006; 13:175-181 (Pubitemid 43755858)
38. Peled A, Kollet O, Ponomaryov T, Petit I, Franitza S, Grabovsky V, et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4 and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 2000; 95:3289-96.